A.A. VASILEVA¹, O.A. BAREYCHEVA²

 ¹Kazan State Medical University, Kazan

²Republic Clinical Hospital, Kazan

Contact details:

Vasileva A.A. — PhD (medicine), Associate Professor of the Department of Clinical Immunology and Allergology

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-987-188-63-44, e-mail: a-v.doc@mail.ru

Allergen-specific immunotherapy (ASIT) is known to be a course-modifying treatment of allergic diseases. This includes reduction in disease progression, declined risks of complications, minimization of further sensitization to allergens, and decreased risk of bronchial asthma development in patients with allergic rhinitis. The article presents characteristics and composition of various medication allergens used for allergen-specific immunotherapy. The authors describe salt extracts of allergens used for subcutaneous ASIT; allergoids received by allergen polymerization with formaldehyde or by carbamoylation; allergens adsorbed on calcium phosphate suspension or aluminum hydroxide used for subcutaneous ASIT; and allergens for sublingual use. Besides, perspectives in allergen synthesis are described, including creation of recombinant allergens. It is also showed how improvement in therapeautical allergens’ preparation influences their effectiveness and safety of use and creates more possibilities in allergens application.

Key words: therapeutic allergens, allergen-specific immunotherapy, allergen salt extracts, allergoids, allergens for sublingual use.

(For citation: Vasileva A.A., Bareycheva O.A. Risk factors for diabetic retinopathy in women with type 2 diabetes. Practical medicine. 2023. Vol. , № , P.)

REFERENCES

1. Allergologiya. Federal’nye klinicheskie rekomendatsii, pod red. R.M. Khaitova, N.I. Il’inoy [Allergology. Federal clinical guidelines, edited by R.M. Khaitova, N.I. Ilyina]. Moscow: Farmarus Print Media, 2014. 126 p.
2. Ignatov A.A., Ramenskaya G.V., Smirnov V.V. Current trends in the standardization of allergen preparations. Farmakokinetika i farmakodinamika, 2015, no. 1, pp. 16–20 (in Russ.).
3. Bokov D.O., Smirnov V.V. Improving methods for standardizing extracts of medicinal allergens: from PNU to LC-MS. Immunopatologiya, allergologiya, infektologiya, 2013, no. 4, pp. 31–41 (in Russ.).
4. Code of Federal Regulations Food and Drug Administration (21 680.1). Allergenic Products, 2011, vol. 7, pp. 133–136.
5. Bokov D.O., Smirnov V.V. On the issue of standardization of allergenic extracts: ways of further development. Sechenovskiy vestnik, 2013, no. 4, pp. 39–46 (in Russ.).
6. Kurbacheva O.M., Pavlova K.S., Kozulina I.E. Allergen-specific immunotherapy: history, methods and new opportunities. Meditsinskiy sovet, 2013, no. 3, pp. 10–19 (in Russ.).
7. Buyanova T.A., Taube A.A. Analysis of the structure of the market for allergen-specific immunotherapy drugs. Vestnik Voronezhskogo gosudarstvennogo universiteta. Seriya: Khimiya. Biologiya. Farmatsiya, 2021, no. 2, pp. 69–75 (in Russ.).
8. Petrova S.Yu., Berzhets V.M., Petrova N.S. et al. Prospects for the development of therapeutic forms of allergens. From abstract problems to concrete solutions. Immunopatologiya, allergologiya, infektologiya, 2018, no. 1, pp. 40–47 (in Russ.).
9. Petrov R.V., Khaitov R.M., Nekrasov A.V. et al. Allergotropin dlya lecheniya pollinozov i sposob lecheniya pollinozov. Patent no. 2205661 ot 13.07.2001 [Allergotropin for the treatment of hay fever and a method for treating hay fever. Patent No. 2205661 dated July 13, 2001]. Pp. 1–5.
10. Ignatov A.A., Ramenskaya G.V., Smirnov V.V. Current trends in the standardization of allergen preparations. Farmakokinetika i farmakodinamika, 2015, no. 1, pp. 16–20 (in Russ.).
11. Lockey R.F. “ARIA”: global guidelines and new forms of allergen immunotherapy. J Allergy Clin Immunol, 2001, vol. 108 (4), pp. 497–499.
12. Urry Z.L., Richards D.F., Black C. et al. Depigmented polymerized allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3. BMC Immunol, 2014. DOI: 10.1186/1471-2172-15-21
13. Bokov D.O., Smirnov V.V., Demina N.B. Production and standardization of pollen allergenic extracts. Razrabotka i registratsiya lekarstvennykh sredstv, 2014, no. 9, pp. 68–84 (in Russ.).
14. Danilycheva I.V., Il’ina N.I., Shul’zhenko A.E. Experience of using carbamylated monomeric allergoid Lais® for sublingual immunotherapy of patients with allergic rhinoconjunctivitis caused by grass pollen. Rossiyskiy allergologicheskiy zhurnal, 2013, no. 10 (6), pp. 58–63 (in Russ.).
15. Kurbacheva O.M., Pavlova K.S., Galitskaya M.A. llergen-specific immunotherapy. Analytical review of modern international and domestic position documents. Rossiyskiy allergologicheskiy zhurnal, 2017, vol. 14, no. 1, pp. 24–32 (in Russ.).
16. Bauer C.S., Rank M.A. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy. J. Allergy Clin. Immunol, 2014, vol. 134, pp. 65–765.
17. Kurbacheva O.M., Amanturlieva M.E. The role of the barrier function of mucous membranes in allergic diseases and in sublingual allergen-specific immunotherapy. Byulleten’ sibirskoy meditsiny, 2017, vol. 16, no. 2, pp. 32–46 (in Russ.).
18. Nevskaya L.V., Lavrenchik E.I., Zhdanova M.Yu., Fadeykina O.V., Kapitanova V.K. International experience in standardization of allergen preparations. BIO preparaty. Profilaktika, diagnostika, lechenie, 2017, vol. 17, no. 4, pp. 222–229 (in Russ.).
19. Peredel’skaya M.Yu., Nenasheva N.M. Sublingual immunotherapy with a new house dust mite allergen: effectiveness and safety. Prakticheskaya allergologiya, 2021, no. 2, pp. 20–29 (in Russ.).
20. Pavlova K.S., Kurbacheva O.M. Modern ASIT strategies for patients with hay fever and hypersensitivity to meadow grass pollen. Rossiyskiy allergologicheskiy zhurnal, 2015, no. 4, pp. 16–26 (in Russ.).
21. Pavlova K.S., Kurbacheva O.M., Galitskaya M.A., Smirnov D.S. Current ideas about the mechanisms of allergen-specific immunotherapy, potential markers of effectiveness and ways of improvement. Rossiyskiy allergologicheskiy zhurnal, 2017, no. 4–5, pp. 5–17 (in Russ.).
22. Pavlov A.E., Seylieva N.A., Mukhortykh O.Yu., Stefanov V.E. Preparation and evaluation of the properties of a recombinant analogue of the major birch pollen allergen Bet v 1. Rossiyskiy allergologicheskiy zhurnal, 2012, no. 3, pp. 7–13 (in Russ.).
23. Petrova S.Yu., Khlgatyan S.V., Berzhets V.M., Vasil’eva A.V. Allergen-containing vaccines for specific immunotherapy. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 2021, vol. 98, no. 1, pp. 104–112 (in Russ.).